Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia. | Cancers (Basel) | 2022 | 36230804 | PubTator, text mining | PubMed |
| Identification of Immuno-Targeted Combination Therapies Using Explanatory Subgroup Discovery for Cancer Patients with EGFR Wild-Type Gene. | Cancers (Basel) | 2022 | 36230688 | PubTator, text mining | PubMed |
| Therapeutic strategies for gastric cancer targeting immune cells: Future directions. | Front Immunol | 2022 | 36225938 | PubTator, text mining | PubMed |
| The tempo and mode of gene regulatory programs during bacterial infection. | Cell Rep | 2022 | 36223751 | PubTator, text mining | PubMed |
| Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand. | Emerg Infect Dis | 2022 | 36220131 | PubTator, text mining | PubMed |
| Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond. | Med Princ Pract | 2022 | 36219943 | PubTator, text mining | PubMed |
| Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies. | Oncoimmunology | 2022 | 36211808 | PubTator, text mining | PubMed |
| Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies. | Front Pharmacol | 2022 | 36210846 | PubTator, text mining | PubMed |
| A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions. | PLoS One | 2022 | 36201506 | PubTator, text mining | PubMed |
| IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient. | Clin Immunol | 2022 | 36189576 | PubTator, text mining | PubMed |
| Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer. | Front Immunol | 2022 | 36189269 | PubTator, text mining | PubMed |
| Adenosine signaling: Optimal target for gastric cancer immunotherapy. | Front Immunol | 2022 | 36189223 | PubTator, text mining | PubMed |
| BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies. | J Hematol Oncol | 2022 | 36183125 | PubTator, text mining | PubMed |
| AVT02: An Adalimumab Biosimilar. | Clin Drug Investig | 2022 | 36181655 | PubTator, text mining | PubMed |
| Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report. | Medicine (Baltimore) | 2022 | 36181052 | PubTator, text mining | PubMed |
| Expression of ICOS in the salivary glands of patients with primary Sjogren's syndrome and its molecular mechanism. | Mol Med Rep | 2022 | 36177915 | PubTator, text mining | PubMed |
| HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives. | Biomark Res | 2022 | 36175985 | PubTator, text mining | PubMed |
| SARS-CoV-2-specicific humoral immunity in convalescent patients with mild COVID-19 is supported by CD4+ T-cell help and negatively correlated with Alphacoronavirus-specific antibody titer. | Immunol Lett | 2022 | 36174771 | PubTator, text mining | PubMed |
| Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease. | Diabetes Care | 2022 | 36174116 | PubTator, text mining | PubMed |
| Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis. | J Immunother Cancer | 2022 | 36171010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=38